van Laarhoven HWM - Search Results

1

SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer.

van den Boorn HG, Abu-Hanna A, Ter Veer E, van Kleef JJ, Lordick F, Stahl M, Ajani JA, Guimbaud R, Park SH, Dutton SJ, Bang YJ, Boku N, Mohammad NH, Sprangers MAG, Verhoeven RHA, Zwinderman AH, van Oijen MGH, van Laarhoven HWM. van den Boorn HG, et al. Among authors: van oijen mgh, van kleef jj, van laarhoven hwm. Cancers (Basel). 2019 Feb 5;11(2):187. doi: 10.3390/cancers11020187. Cancers (Basel). 2019. PMID: 30764578 Free PMC article.

2

The life in sight application study (LISA): design of a randomized controlled trial to assess the role of an assisted structured reflection on life events and ultimate life goals to improve quality of life of cancer patients.

Kruizinga R, Scherer-Rath M, Schilderman JB, Sprangers MA, Van Laarhoven HW. Kruizinga R, et al. BMC Cancer. 2013 Jul 26;13:360. doi: 10.1186/1471-2407-13-360. BMC Cancer. 2013. PMID: 23889978 Free PMC article. Clinical Trial.

3

Burden of spousal caregivers of stage II and III esophageal cancer survivors 3 years after treatment with curative intent.

Haj Mohammad N, Walter AW, van Oijen MG, Hulshof MC, Bergman JJ, Anderegg MC, van Berge Henegouwen MI, Henselmans I, Sprangers MA, van Laarhoven HW. Haj Mohammad N, et al. Support Care Cancer. 2015 Dec;23(12):3589-98. doi: 10.1007/s00520-015-2727-4. Epub 2015 Apr 18. Support Care Cancer. 2015. PMID: 25894882 Free PMC article.

4

The effect of spiritual interventions addressing existential themes using a narrative approach on quality of life of cancer patients: a systematic review and meta-analysis.

Kruizinga R, Hartog ID, Jacobs M, Daams JG, Scherer-Rath M, Schilderman JB, Sprangers MA, Van Laarhoven HW. Kruizinga R, et al. Psychooncology. 2016 Mar;25(3):253-65. doi: 10.1002/pon.3910. Epub 2015 Aug 10. Psychooncology. 2016. PMID: 26257308 Review.

5

Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis.

Mohammad NH, ter Veer E, Ngai L, Mali R, van Oijen MG, van Laarhoven HW. Mohammad NH, et al. Cancer Metastasis Rev. 2015 Sep;34(3):429-41. doi: 10.1007/s10555-015-9576-y. Cancer Metastasis Rev. 2015. PMID: 26267802 Free PMC article. Review.

6

Metformin Use During Treatment of Potentially Curable Esophageal Cancer Patients is not Associated with Better Outcomes.

Spierings LE, Lagarde SM, van Oijen MG, Gisbertz SS, Wilmink JW, Hulshof MC, Meijer SL, Anderegg MC, van Berge Henegouwen MI, van Laarhoven HW. Spierings LE, et al. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S766-71. doi: 10.1245/s10434-015-4850-3. Epub 2015 Sep 8. Ann Surg Oncol. 2015. PMID: 26350367

7

The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis.

Ter Veer E, Mohammad NH, Lodder P, Ngai LL, Samaan M, van Oijen MG, van Laarhoven HW. Ter Veer E, et al. Gastric Cancer. 2016 Jul;19(3):696-712. doi: 10.1007/s10120-015-0587-8. Epub 2016 Jan 11. Gastric Cancer. 2016. PMID: 26754295 Free PMC article. Review.

8

S-1 with leucovorin and oxaliplatin for advanced gastric cancer.

Ter Veer E, van Oijen MGH, van Laarhoven HWM. Ter Veer E, et al. Among authors: van oijen mgh, van laarhoven hwm. Lancet Oncol. 2016 Feb;17(2):e41. doi: 10.1016/S1470-2045(16)00005-X. Lancet Oncol. 2016. PMID: 26868348 No abstract available.

9

Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature.

Ter Veer E, Haj Mohammad N, van Valkenhoef G, Ngai LL, Mali RM, van Oijen MG, van Laarhoven HW. Ter Veer E, et al. Cancer Metastasis Rev. 2016 Sep;35(3):439-56. doi: 10.1007/s10555-016-9632-2. Cancer Metastasis Rev. 2016. PMID: 27417221 Free PMC article. Review.

10

The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis.

Ter Veer E, Haj Mohammad N, van Valkenhoef G, Ngai LL, Mali RMA, Anderegg MC, van Oijen MGH, van Laarhoven HWM. Ter Veer E, et al. Among authors: van oijen mgh, van laarhoven hwm, van valkenhoef g. J Natl Cancer Inst. 2016 Aug 30;108(10). doi: 10.1093/jnci/djw166. Print 2016 Oct. J Natl Cancer Inst. 2016. PMID: 27576566 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

569 results

Search Page